Cannell Capital - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 22 filers reported holding PSYCHEMEDICS CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cannell Capital ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q2 2023$341,061
-13.1%
74,7940.0%0.07%
-10.5%
Q1 2023$392,668
+7.0%
74,7940.0%0.08%
+2.7%
Q4 2022$366,842
-36.2%
74,794
-16.2%
0.07%
-43.9%
Q3 2022$575,000
+1.6%
89,2110.0%0.13%
+15.8%
Q2 2022$566,000
+4.8%
89,211
+13.9%
0.11%
+39.0%
Q1 2022$540,000
+8.4%
78,306
+10.3%
0.08%
+3.8%
Q4 2021$498,00071,0000.08%
Other shareholders
PSYCHEMEDICS CORP shareholders Q2 2023
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 41,501$189,2430.08%
SANTA MONICA PARTNERS LP 20,000$910.07%
Cannell Capital 74,794$341,0610.07%
RBF Capital, LLC 144,231$657,6930.04%
CRAWFORD INVESTMENT COUNSEL INC 242,113$1,104,0340.02%
Ancora Advisors, LLC 78,373$357,3800.01%
WEDBUSH SECURITIES INC 34,157$1560.01%
Renaissance Technologies 277,963$1,2680.00%
CALDWELL SUTTER CAPITAL, INC. 577$2,6310.00%
Tower Research Capital LLC (TRC) 876$3,9950.00%
View complete list of PSYCHEMEDICS CORP shareholders